|
OceanDocs >
Africa >
Kenya >
Kenya Marine and Fisheries Research Institute >
Other Reports >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/1834/1291
|
| Title: | Novel Pharmaceuticals from Kenyan Marine Cyanobacteria |
| Authors: | Dzeha, T. |
| ASFA Terms: | Bacteria
Pharmaceutical products |
| Issue Date: | 2004 |
| Abstract: | Two projects undertaken at the Heriot-Watt University, Edinburgh, U.K as part of the
WIOMSA Marg II Programme are presented here. Project 1 was on studies carried
out on the Kenyan marine cyanobacterium Lyngbya majuscula, which was collected
from Shimoni, 100 km south of Mombasa, Kenya and ferried to the U.K on 12th
October 2003. Specifically, L. majuscula was investigated on the potential for
bioprocess intensified production of secondary metabolites with therapeutic potential,
the Chemistry of its secondary metabolites and that of the cultures, and on the 16S
rDNA classification of its epiphytic bacteria isolates. Project 2 focused on the
isolation of cell-cell signaling inducer compounds from biofilms of marine bacteria
Bacillus licheniformis EI-34-6. |
| Description: | WIOMSA/MARG-II/2004/03 |
| URI: | http://hdl.handle.net/1834/1291 |
| Related document: | http://www.wiomsa.org/ |
| Appears in Collections: | Other Reports
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|
